Most ED Visits Happen at Corporate-Owned Facilities
Fewer than half occurred at facilities owned by clinicians
Related Articles
FDA Restricts Gene Therapy Skysona Due to Blood Cancer Risk
Treatment should be used only in CALD patients without suitable alternative options
Brain Autopsies Suggest MIND Diet Reduces Pathology
Diet-dementia relationship was partly mediated by hippocampal sclerosis, data suggest
Dariush Mozaffarian and Emily Callahan on Nutrition Support in GLP-1 Therapy
OMA has a new on the critical role of nutritional support for patients with obesity during treatment with glucagon-like peptide 1 receptor agonists (GLP-1s). The…
Deion Sanders’ Cancer Diagnosis: Here’s What to Know
‘Prime Time’ as patient: former NFL star, college football coach talks about his bladder tumor
Tirzepatide’s CV Benefit; PREVENT Age Calculator; Rectal Injection for BP Reduction?
Recent developments of interest in cardiovascular medicine
Nation’s IV Saline Shortage Is Over, FDA Declares
Shortage in part stemmed from hurricane damage to key North Carolina facility in 2024
KRAS Inhibitor Reduces Progression Risk in Pretreated Lung Cancer
Overall survival data still outstanding for adagrasib in KRAS G12C-mutated advanced NSCLC
Novel Drug for HER2-Mutant Lung Cancer Wins FDA Approval
Zongertinib induced responses in 75% of mutation carriers with non-squamous NSCLC
Prophylactic Antibiotics May Be of No Use in Cirrhosis With Upper GI Bleeding
Findings contradict current guidelines, suggesting a need for new randomized trials
First-in-Nation State Law Requires ‘Restorative Reproductive Medicine’ Coverage
Critics say the practice is ideologically driven, deceptive to patients, and often excludes IVF